1.0(top 50%)
impact factor
3.0K(top 10%)
papers
2.1K(top 50%)
citations
16(top 50%)
h-index
1.0(top 50%)
extended IF
3.4K
all documents
2.3K
doc citations
30(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Online pharmacies: desirable characteristics and regulationsDrugs and Therapy Perspectives2020202
2Knowledge, attitude and preventive practices related to COVID-19: a cross-sectional study in two Pakistani university populationsDrugs and Therapy Perspectives2020105
3Self-medication during Covid-19 pandemic: challenges and opportunitiesDrugs and Therapy Perspectives202089
4Is Pakistan prepared to tackle the coronavirus epidemic?Drugs and Therapy Perspectives202079
5Coronavirus outbreaks: prevention and management recommendationsDrugs and Therapy Perspectives202038
6Current burden on healthcare systems in low- and middle-income countries: recommendations for emergency care of COVID-19Drugs and Therapy Perspectives202036
7Preventing COVID-19 in low- and middle-income countriesDrugs and Therapy Perspectives202032
8Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systemsDrugs and Therapy Perspectives202130
9Do physicians communicate the adverse effects of medications that older patients want to hear?Drugs and Therapy Perspectives201520
10Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USADrugs and Therapy Perspectives201820
11Preventive measures and management of COVID-19 in pregnancyDrugs and Therapy Perspectives202020
12Ginkgo biloba extract EGb 761® in the symptomatic treatment of mild-to-moderate dementia: a profile of its useDrugs and Therapy Perspectives201818
13Osimertinib as first-line therapy in advanced NSCLC: a profile of its useDrugs and Therapy Perspectives201818
14Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its useDrugs and Therapy Perspectives201818
15Community pharmacists’ attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods studyDrugs and Therapy Perspectives201517
16What will be the role of molnupiravir in the treatment of COVID-19 infection?Drugs and Therapy Perspectives202117
17Lactulose: a prebiotic, laxative and detoxifying agentDrugs and Therapy Perspectives201716
18Burosumab in X-linked hypophosphatemia: a profile of its use in the USADrugs and Therapy Perspectives201816
19Knowledge and beliefs towards universal safety precautions during the coronavirus disease (COVID-19) pandemic among the Indian public: a web-based cross-sectional surveyDrugs and Therapy Perspectives202015
20DTaP-IPV-Hep B-Hib vaccine (Hexyon®/Hexacima®): a guide to its use in the primary and booster vaccination of infants and toddlers in EuropeDrugs and Therapy Perspectives201314
21Afatinib in advanced NSCLC: a profile of its useDrugs and Therapy Perspectives201814
22Anakinra in Still’s disease: a profile of its useDrugs and Therapy Perspectives201814
23Current pharmacy practices in low- and middle-income countries; recommendations in response to the COVID-19 pandemicDrugs and Therapy Perspectives202013
24Ketoconazole in Cushing’s syndrome: a profile of its useDrugs and Therapy Perspectives202113
25Ban on the use of cannabinoids in all sports during competition is supported by World Anti-Doping Agency criteriaDrugs and Therapy Perspectives201212
26Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USADrugs and Therapy Perspectives201812
27Emerging small molecule antivirals may fit neatly into COVID-19 treatmentDrugs and Therapy Perspectives202212
28Are some orphan drugs for rare diseases too expensive? A study of purchase versus compounding costsDrugs and Therapy Perspectives201111
29A review on therapeutic drug monitoring of the mTOR class of immunosuppressants: everolimus and sirolimusDrugs and Therapy Perspectives201711
30Quantitative exploration of medication errors among older people: a systematic reviewDrugs and Therapy Perspectives201811
31Macrogol (polyethylene glycol) 4000 without electrolytes in the symptomatic treatment of chronic constipation: a profile of its useDrugs and Therapy Perspectives201811
32Management and evaluation of treatment adherence and effectiveness in chronic venous disorders: results of the international study VEIN Act ProgramDrugs and Therapy Perspectives201911
33Paradigm shift of drug information centers during the COVID-19 pandemicDrugs and Therapy Perspectives202011
34The COVID-19 pandemic threatens the Expanded Program on Immunization: recommendations for sustaining vaccination goalsDrugs and Therapy Perspectives202011
35Ban on the use of cannabinoids in all sports during competition is supported by World Anti-Doping Agency criteriaDrugs and Therapy Perspectives201211
36Factors responsible for noncompliance to drug therapy in the elderly and the impact of patient education on improving complianceDrugs and Therapy Perspectives201310
37Riluzole oral suspension in amyotrophic lateral sclerosis: a guide to its useDrugs and Therapy Perspectives201610
38Responding to drug shortages and rising costs: IV chemotherapy drug use optimization achieved by closed safety devices in hospital pharmaciesDrugs and Therapy Perspectives201610
39Daratumumab in multiple myeloma: a guide to its use as monotherapy in the EUDrugs and Therapy Perspectives20169
40Teamwork for innovation in pharmacy practice: from traditional to flexible teamsDrugs and Therapy Perspectives20189
41Assessment of anticoagulation management in outpatients attending a warfarin clinic in Windhoek, NamibiaDrugs and Therapy Perspectives20199
42Is Pakistan on track to have COVID-19 transmission and mortality rates similar to those of Italy, Iran or the USA?Drugs and Therapy Perspectives20209
43Community pharmacists’ knowledge of and attitudes toward antibiotic use, resistance, and self-medication in JordanDrugs and Therapy Perspectives20219
44Will the reform of community pharmacies in Italy be of benefit to patients or the Italian National Health Service?Drugs and Therapy Perspectives20129
45RTS,S/AS01 malaria vaccine (Mosquirix®): a profile of its useDrugs and Therapy Perspectives20229
46Drug-induced uveitis can usually be easily managedDrugs and Therapy Perspectives19988
47Grapefruit warning labelDrugs and Therapy Perspectives19988
48Will the reform of community pharmacies in Italy be of benefit to patients or the Italian National Health Service?Drugs and Therapy Perspectives20128
49Standardized sublingual allergen extract solution (Staloral®): a guide to its use as allergen-specific immunotherapyDrugs and Therapy Perspectives20148
50Trifluridine/tipiracil in metastatic colorectal cancer: a guide to its useDrugs and Therapy Perspectives20178